▶ 調査レポート

世界の腫瘍マーカー検査市場：市場規模・現状・予測
• 英文タイトル：Global Tumor Marker Testing Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の腫瘍マーカー検査市場：市場規模・現状・予測 / Global Tumor Marker Testing Market Size, Status and Forecast 2019-2025 / QYR9N8147資料のイメージです。• レポートコード：QYR9N8147
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、腫瘍マーカー検査のグローバル市場について調査・分析したレポートで、種類別（生化学マーカー、がん遺伝子、成長因子、ホルモン、コロニー刺激因子、その他）、用途別（病院、商業/民間研究所、医師のオフィス/グループプラクティス、がんクリニック、外来治療センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・腫瘍マーカー検査の世界市場規模
・主要企業別市場シェア
・腫瘍マーカー検査の世界市場規模：種類別（生化学マーカー、がん遺伝子、成長因子、ホルモン、コロニー刺激因子、その他）
・腫瘍マーカー検査の世界市場規模：用途別（病院、商業/民間研究所、医師のオフィス/グループプラクティス、がんクリニック、外来治療センター）
・腫瘍マーカー検査のアメリカ市場規模（種類別、用途別）
・腫瘍マーカー検査のヨーロッパ市場規模（種類別、用途別）
・腫瘍マーカー検査の中国市場規模（種類別、用途別）
・腫瘍マーカー検査の日本市場規模（種類別、用途別）
・腫瘍マーカー検査の東南アジア市場規模（種類別、用途別）
・腫瘍マーカー検査のインド市場規模（種類別、用途別）
・腫瘍マーカー検査の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・腫瘍マーカー検査の世界市場予測（2019年-2025年）
・腫瘍マーカー検査の地域別市場予測（2019年-2025年）
...

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
In 2018, the global Tumor Marker Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Tumor Marker Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Marker Testing development in United States, Europe and China.

The key players covered in this study
Abbott Diagnostics
Affymetrix
Agilent Technologies
Beckman，Dickinson（BD）
BioCurex
BioModa
Clarient
Correlogic Systems
Epigenomics
Hologic
Roche Diagnostics

Market segment by Type, the product can be split into
Biochemical Markers
Oncogenes
Growth Factors
Hormones
Colony Stimulating Factors
Lymphokines
Immunohistochemical Stains
Others

Market segment by Application, split into
Hospitals
Commercial/Private Laboratories
Physician Offices/Group Practices
Cancer Clinics
Ambulatory Care Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tumor Marker Testing status, future forecast, growth opportunity, key market and key players.
To present the Tumor Marker Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tumor Marker Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tumor Marker Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 Biochemical Markers
1.4.3 Oncogenes
1.4.4 Growth Factors
1.4.5 Hormones
1.4.6 Colony Stimulating Factors
1.4.7 Lymphokines
1.4.8 Immunohistochemical Stains
1.4.9 Others
1.5 Market by Application
1.5.1 Global Tumor Marker Testing Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Commercial/Private Laboratories
1.5.4 Physician Offices/Group Practices
1.5.5 Cancer Clinics
1.5.6 Ambulatory Care Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Tumor Marker Testing Market Size
2.2 Tumor Marker Testing Growth Trends by Regions
2.2.1 Tumor Marker Testing Market Size by Regions (2014-2025)
2.2.2 Tumor Marker Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Tumor Marker Testing Market Size by Manufacturers
3.1.1 Global Tumor Marker Testing Revenue by Manufacturers (2014-2019)
3.1.2 Global Tumor Marker Testing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Tumor Marker Testing Market Concentration Ratio (CR5 and HHI)
3.2 Tumor Marker Testing Key Players Head office and Area Served
3.3 Key Players Tumor Marker Testing Product/Solution/Service
3.4 Date of Enter into Tumor Marker Testing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Tumor Marker Testing Market Size by Type (2014-2019)
4.2 Global Tumor Marker Testing Market Size by Application (2014-2019)

5 United States
5.1 United States Tumor Marker Testing Market Size (2014-2019)
5.2 Tumor Marker Testing Key Players in United States
5.3 United States Tumor Marker Testing Market Size by Type
5.4 United States Tumor Marker Testing Market Size by Application

6 Europe
6.1 Europe Tumor Marker Testing Market Size (2014-2019)
6.2 Tumor Marker Testing Key Players in Europe
6.3 Europe Tumor Marker Testing Market Size by Type
6.4 Europe Tumor Marker Testing Market Size by Application

7 China
7.1 China Tumor Marker Testing Market Size (2014-2019)
7.2 Tumor Marker Testing Key Players in China
7.3 China Tumor Marker Testing Market Size by Type
7.4 China Tumor Marker Testing Market Size by Application

8 Japan
8.1 Japan Tumor Marker Testing Market Size (2014-2019)
8.2 Tumor Marker Testing Key Players in Japan
8.3 Japan Tumor Marker Testing Market Size by Type
8.4 Japan Tumor Marker Testing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Tumor Marker Testing Market Size (2014-2019)
9.2 Tumor Marker Testing Key Players in Southeast Asia
9.3 Southeast Asia Tumor Marker Testing Market Size by Type
9.4 Southeast Asia Tumor Marker Testing Market Size by Application

10 India
10.1 India Tumor Marker Testing Market Size (2014-2019)
10.2 Tumor Marker Testing Key Players in India
10.3 India Tumor Marker Testing Market Size by Type
10.4 India Tumor Marker Testing Market Size by Application

11 Central & South America
11.1 Central & South America Tumor Marker Testing Market Size (2014-2019)
11.2 Tumor Marker Testing Key Players in Central & South America
11.3 Central & South America Tumor Marker Testing Market Size by Type
11.4 Central & South America Tumor Marker Testing Market Size by Application

12 International Players Profiles
12.1 Abbott Diagnostics
12.1.1 Abbott Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tumor Marker Testing Introduction
12.1.4 Abbott Diagnostics Revenue in Tumor Marker Testing Business (2014-2019)
12.1.5 Abbott Diagnostics Recent Development
12.2 Affymetrix
12.2.1 Affymetrix Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tumor Marker Testing Introduction
12.2.4 Affymetrix Revenue in Tumor Marker Testing Business (2014-2019)
12.2.5 Affymetrix Recent Development
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tumor Marker Testing Introduction
12.3.4 Agilent Technologies Revenue in Tumor Marker Testing Business (2014-2019)
12.3.5 Agilent Technologies Recent Development
12.4 Beckman，Dickinson（BD）
12.4.1 Beckman，Dickinson（BD） Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tumor Marker Testing Introduction
12.4.4 Beckman，Dickinson（BD） Revenue in Tumor Marker Testing Business (2014-2019)
12.4.5 Beckman，Dickinson（BD） Recent Development
12.5 BioCurex
12.5.1 BioCurex Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tumor Marker Testing Introduction
12.5.4 BioCurex Revenue in Tumor Marker Testing Business (2014-2019)
12.5.5 BioCurex Recent Development
12.6 BioModa
12.6.1 BioModa Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tumor Marker Testing Introduction
12.6.4 BioModa Revenue in Tumor Marker Testing Business (2014-2019)
12.6.5 BioModa Recent Development
12.7 Clarient
12.7.1 Clarient Company Details
12.7.2 Company Description and Business Overview
12.7.3 Tumor Marker Testing Introduction
12.7.4 Clarient Revenue in Tumor Marker Testing Business (2014-2019)
12.7.5 Clarient Recent Development
12.8 Correlogic Systems
12.8.1 Correlogic Systems Company Details
12.8.2 Company Description and Business Overview
12.8.3 Tumor Marker Testing Introduction
12.8.4 Correlogic Systems Revenue in Tumor Marker Testing Business (2014-2019)
12.8.5 Correlogic Systems Recent Development
12.9 Epigenomics
12.9.1 Epigenomics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Tumor Marker Testing Introduction
12.9.4 Epigenomics Revenue in Tumor Marker Testing Business (2014-2019)
12.9.5 Epigenomics Recent Development
12.10 Hologic
12.10.1 Hologic Company Details
12.10.2 Company Description and Business Overview
12.10.3 Tumor Marker Testing Introduction
12.10.4 Hologic Revenue in Tumor Marker Testing Business (2014-2019)
12.10.5 Hologic Recent Development
12.11 Roche Diagnostics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Tumor Marker Testing Key Market Segments
Table Key Players Tumor Marker Testing Covered
Table Global Tumor Marker Testing Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Tumor Marker Testing Market Size Market Share by Type 2014-2025
Figure Biochemical Markers Figures
Table Key Players of Biochemical Markers
Figure Oncogenes Figures
Table Key Players of Oncogenes
Figure Growth Factors Figures
Table Key Players of Growth Factors
Figure Hormones Figures
Table Key Players of Hormones
Figure Colony Stimulating Factors Figures
Table Key Players of Colony Stimulating Factors
Figure Lymphokines Figures
Table Key Players of Lymphokines
Figure Immunohistochemical Stains Figures
Table Key Players of Immunohistochemical Stains
Figure Others Figures
Table Key Players of Others
Table Global Tumor Marker Testing Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Commercial/Private Laboratories Case Studies
Figure Physician Offices/Group Practices Case Studies
Figure Cancer Clinics Case Studies
Figure Ambulatory Care Centers Case Studies
Figure Tumor Marker Testing Report Years Considered
Table Global Tumor Marker Testing Market Size 2014-2025 (Million US$)
Figure Global Tumor Marker Testing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tumor Marker Testing Market Size by Regions 2014-2025 (Million US$)
Table Global Tumor Marker Testing Market Size by Regions 2014-2019 (Million US$)
Table Global Tumor Marker Testing Market Share by Regions 2014-2019
Figure Global Tumor Marker Testing Market Share by Regions 2014-2019
Figure Global Tumor Marker Testing Market Share by Regions 2019
Table Market Top Trends
Table Global Tumor Marker Testing Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Tumor Marker Testing Market Share by Manufacturers (2014-2019)
Figure Global Tumor Marker Testing Market Share by Manufacturers in 2018
Table Global Tumor Marker Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tumor Marker Testing Product/Solution/Service
Table Date of Enter into Tumor Marker Testing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tumor Marker Testing Market Size by Type (2014-2019) (Million US$)
Table Global Tumor Marker Testing Market Size Share by Type (2014-2019)
Figure Global Tumor Marker Testing Market Size Market Share by Type (2014-2019)
Table Global Tumor Marker Testing Market Size by Application (2014-2019) (Million US$)
Table Global Tumor Marker Testing Market Size Share by Application (2014-2019)
Figure Global Tumor Marker Testing Market Size Market Share by Application (2014-2019)
Figure Global Tumor Marker Testing Revenue Market Share by Application in 2018
Figure United States Tumor Marker Testing Market Size 2014-2019 (Million US$)
Table United States Key Players Tumor Marker Testing Revenue (2018-2019) (Million US$)
Table United States Key Players Tumor Marker Testing Market Share (2018-2019)
Table United States Tumor Marker Testing Market Size by Type (2014-2019) (Million US$)
Table United States Tumor Marker Testing Market Share by Type (2014-2019)
Table United States Tumor Marker Testing Market Size by Application (2014-2019) (Million US$)
Table United States Tumor Marker Testing Market Share by Application (2014-2019)
Figure Europe Tumor Marker Testing Market Size 2014-2019 (Million US$)
Table Europe Key Players Tumor Marker Testing Revenue (2018-2019) (Million US$)
Table Europe Key Players Tumor Marker Testing Market Share (2018-2019)
Table Europe Tumor Marker Testing Market Size by Type (2014-2019) (Million US$)
Table Europe Tumor Marker Testing Market Share by Type (2014-2019)
Table Europe Tumor Marker Testing Market Size by Application (2014-2019) (Million US$)
Table Europe Tumor Marker Testing Market Share by Application (2014-2019)
Figure China Tumor Marker Testing Market Size 2014-2019 (Million US$)
Table China Key Players Tumor Marker Testing Revenue (2018-2019) (Million US$)
Table China Key Players Tumor Marker Testing Market Share (2018-2019)
Table China Tumor Marker Testing Market Size by Type (2014-20189) (Million US$)
Table China Tumor Marker Testing Market Share by Type (2014-2019)
Table China Tumor Marker Testing Market Size by Application (2014-2019) (Million US$)
Table China Tumor Marker Testing Market Share by Application (2014-2019)
Figure Japan Tumor Marker Testing Market Size 2014-2019 (Million US$)
Table Japan Key Players Tumor Marker Testing Revenue (2018-2019) (Million US$)
Table Japan Key Players Tumor Marker Testing Market Share (2018-2019)
Table Japan Tumor Marker Testing Market Size by Type (2014-2019) (Million US$)
Table Japan Tumor Marker Testing Market Share by Type (2014-2019)
Table Japan Tumor Marker Testing Market Size by Application (2014-2019) (Million US$)
Table Japan Tumor Marker Testing Market Share by Application (2014-2019)
Figure Southeast Asia Tumor Marker Testing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tumor Marker Testing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tumor Marker Testing Market Share (2018-2019)
Table Southeast Asia Tumor Marker Testing Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Tumor Marker Testing Market Share by Type (2014-2019)
Table Southeast Asia Tumor Marker Testing Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Tumor Marker Testing Market Share by Application (2014-2019)
Figure India Tumor Marker Testing Market Size 2014-2019 (Million US$)
Table India Key Players Tumor Marker Testing Revenue (2018-2019) (Million US$)
Table India Key Players Tumor Marker Testing Market Share (2018-2019)
Table India Tumor Marker Testing Market Size by Type (2014-2019) (Million US$)
Table India Tumor Marker Testing Market Share by Type (2014-2019)
Table India Tumor Marker Testing Market Size by Application (2014-2019) (Million US$)
Table India Tumor Marker Testing Market Share by Application (2014-2019)
Figure Central & South America Tumor Marker Testing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tumor Marker Testing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tumor Marker Testing Market Share (2018-2019)
Table Central & South America Tumor Marker Testing Market Size by Type (2014-2019) (Million US$)
Table Central & South America Tumor Marker Testing Market Share by Type (2014-2019)
Table Central & South America Tumor Marker Testing Market Size by Application (2014-2019) (Million US$)
Table Central & South America Tumor Marker Testing Market Share by Application (2014-2019)
Table Abbott Diagnostics Company Details
Table Abbott Diagnostics Revenue in Tumor Marker Testing Business (2014-2019) (Million US$)
Figure Abbott Diagnostics Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table Abbott Diagnostics Recent Development
Table Affymetrix Company Details
Table Affymetrix Revenue in Tumor Marker Testing Business (2014-2019)(Million US$)
Figure Affymetrix Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table Affymetrix Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Tumor Marker Testing Business (2014-2019)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table Agilent Technologies Recent Development
Table Beckman，Dickinson（BD） Company Details
Table Beckman，Dickinson（BD） Revenue in Tumor Marker Testing Business (2014-2019)(Million US$)
Figure Beckman，Dickinson（BD） Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table Beckman，Dickinson（BD） Recent Development
Table BioCurex Company Details
Table BioCurex Revenue in Tumor Marker Testing Business (2014-2019)(Million US$)
Figure BioCurex Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table BioCurex Recent Development
Table BioModa Company Details
Table BioModa Revenue in Tumor Marker Testing Business (2014-2019)(Million US$)
Figure BioModa Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table BioModa Recent Development
Table Clarient Company Details
Table Clarient Revenue in Tumor Marker Testing Business (2014-2019)(Million US$)
Figure Clarient Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table Clarient Recent Development
Table Correlogic Systems Company Details
Table Correlogic Systems Revenue in Tumor Marker Testing Business (2014-2019)(Million US$)
Figure Correlogic Systems Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table Correlogic Systems Recent Development
Table Epigenomics Company Details
Table Epigenomics Revenue in Tumor Marker Testing Business (2014-2019)(Million US$)
Figure Epigenomics Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table Epigenomics Recent Development
Table Hologic Company Details
Table Hologic Revenue in Tumor Marker Testing Business (2014-2019)(Million US$)
Figure Hologic Revenue Growth Rate in Tumor Marker Testing Business (2014-2019)
Table Hologic Recent Development
Table Roche Diagnostics Company Details
Table Global Tumor Marker Testing Market Size by Regions (Million US$) 2019-2025
Figure Global Tumor Marker Testing Market Size Share by Regions (2019-2025)
Figure Global Tumor Marker Testing Market Size Share by Regions in 2025
Figure United States Tumor Marker Testing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tumor Marker Testing Market Size Forecast (2019-2025)(Million USD)
Figure China Tumor Marker Testing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Tumor Marker Testing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tumor Marker Testing Market Size Forecast (2019-2025)(Million USD)
Figure India Tumor Marker Testing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tumor Marker Testing Market Size Forecast (2019-2025)(Million USD)
Table Global Tumor Marker Testing Market Size by Product (2019-2025) (Million US$)
Figure Global Tumor Marker Testing Market Size by Product (2019-2025)
Figure Global Tumor Marker Testing Market Size by Product in 2025
Table Global Tumor Marker Testing Market Size by Application (2019-2025) (Million US$)
Figure Global Tumor Marker Testing Market Size by Application (2019-2025)
Figure Global Tumor Marker Testing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の分子量マーカー市場：市場規模・現状・予測
    Global Molecular Weight Marker Market Size, Status and Forecast 2019-2025
    QYR9N7592 2019年6月14日 99Pages
    当資料は、分子量マーカーのグローバル市場について調査・分析したレポートで、種類別（RNAマーカー、DNAマーカー、タンパク質マーカー）、用途別（バイオテクノロジーと製薬会社、学術研究機関、受託研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、...
  • 世界の腫瘍治療フィールド（TTFields）市場：市場規模・現状・予測
    Global Tumor Treating Fields (TTFields) Market Size, Status and Forecast 2019-2025
    QYR9N8149 2019年6月14日 94Pages
    当資料は、腫瘍治療フィールド（TTFields）のグローバル市場について調査・分析したレポートで、種類別（低周波、中間周波数）、用途別（病院、診療所、がんおよび放射線療法センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の転移性脊髄腫瘍市場：市場規模・現状・予測
    Global Metastases Spinal Tumor Market Size, Status and Forecast 2019-2025
    QYR9N7549 2019年6月14日 95Pages
    当資料は、転移性脊髄腫瘍のグローバル市場について調査・分析したレポートで、種類別（硬膜外、その他）、用途別（病院と診療所、外来手術センター、学術機関、研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...
  • 世界の小児脳腫瘍市場：市場規模・現状・予測
    Global Pediatric Brain Tumor Market Size, Status and Forecast 2019-2025
    QYR9N7778 2019年6月14日 92Pages
    当資料は、小児脳腫瘍のグローバル市場について調査・分析したレポートで、種類別（神経膠腫、神経膠腫の混合腫瘍、胚性腫瘍、脈絡叢乳頭腫/がん、非神経上皮組織から発生する腫瘍、その他）、用途別（病院と診療所、医学研究センター、学術機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中...
  • 世界の性索性腺間質腫瘍市場：市場規模・現状・予測
    Global Sex Cord Gonadal Stromal Tumor Market Size, Status and Forecast 2019-2025
    QYR9N8024 2019年6月14日 104Pages
    当資料は、性索性腺間質腫瘍のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院での使用、診療所での使用、研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の性腺生殖腺間質腫瘍の治療市場：市場規模・現状・予測
    Global Sex Cord Gonadal Stromal Tumor Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8025 2019年6月14日 93Pages
    当資料は、性腺生殖腺間質腫瘍の治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、手術、その他）、用途別（病院、診療所、がん研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...
  • 世界の診療所診断テスト市場：市場規模・現状・予測
    Global Physician Office Diagnostic Testing Market Size, Status and Forecast 2019-2025
    QYR9N7824 2019年6月14日 92Pages
    当資料は、診療所診断テストのグローバル市場について調査・分析したレポートで、種類別（グルコースモニタリングキット、心血管代謝モニタリングキット、テスト、感染症検査キット、凝固モニタリングキット、その他）、用途別（診断センター、病院、外来治療の設定、研究所、在宅ケア）、主要地域別（アメリカ、ヨーロッパ...
  • 世界の腫瘍バイオマーカー検査市場：市場規模・現状・予測
    Global Tumor Biomarker Test Market Size, Status and Forecast 2019-2025
    QYR9N8146 2019年6月14日 91Pages
    当資料は、腫瘍バイオマーカー検査のグローバル市場について調査・分析したレポートで、種類別（前立腺特異抗原検査、CTCテスト、アルファフェトプロテイン（AFP）試験、CAテスト、HER2テスト、その他）、用途別（肺がん、乳がん、結腸直腸、前立腺がん、血液がん）、主要地域別（アメリカ、ヨーロッパ、中国、...
  • 世界の腫瘍マーカーイムノアッセイ市場：市場規模・現状・予測
    Global Tumor Markers Immunoassay Market Size, Status and Forecast 2019-2025
    QYR9N8148 2019年6月14日 103Pages
    当資料は、腫瘍マーカーイムノアッセイのグローバル市場について調査・分析したレポートで、種類別（ProGRP、PSA（複合型、無料、合計））、SCC（扁平上皮がん抗原）、血清HER-2 / neu、チログロブリン、その他）、用途別（肝臓がん、乳がん、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日...
  • 世界の睡眠障害テスト市場：市場規模・現状・予測
    Global Sleeping Sickness Testing Market Size, Status and Forecast 2019-2025
    QYR9N8058 2019年6月14日 95Pages
    当資料は、睡眠障害テストのグローバル市場について調査・分析したレポートで、種類別（アクティブスクリーニングテスト、病期診断テスト）、用途別（病院、診療所、診断センターと検査室、学術機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...
  • 世界の腫瘍マーカーイムノアッセイ市場：市場規模・現状・予測世界の腫瘍マーカーイムノアッセイ市場：市場規模・現状・予測 In 2018, the global Tumor Markers Immunoassay market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Tumor Markers Immunoassay status, future forecast, growth opportunity, key market and key players. …
  • 世界の分子量マーカー市場：市場規模・現状・予測世界の分子量マーカー市場：市場規模・現状・予測 Molecular weight markers are used to calculate sample molecular weights in the medical research arena. In addition, these markers play a vital role in the monitoring of the progress of an electrophoretic run in separation and analysis of macromolecules. Molecular weight markers include RNA, DNA, and…
  • 世界の腫瘍治療フィールド（TTFields）市場：市場規模・現状・予測世界の腫瘍治療フィールド（TTFields）市場：市場規模・現状・予測 Tumor Treating Field (TTField) is an anticancer treatment which disrupts the tumor cells mitosis. Tumor Treating Field is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer.North America is projected to hold largest…
  • 世界の診療所診断テスト市場：市場規模・現状・予測世界の診療所診断テスト市場：市場規模・現状・予測 Physician office diagnostic testing is similar to the point-of-care diagnostic testing which are carried out in physician’s office, hospital, home and others.The physician office diagnostic testing market is expected to grow at a rapid growth rate over the forecast period owing to the increasing sed…
  • 世界の小児脳腫瘍市場：市場規模・現状・予測世界の小児脳腫瘍市場：市場規模・現状・予測 Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant).Treatment and chance of recovery (progn…